Patent details

EP2563350 Title: THERAPEUTIC REGIMEN AND METHOD FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY

Basic Information

Publication number:
EP2563350
PCT Application Number:
IB2011001294
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117716647
PCT Publication Number:
WO2011132084
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC REGIMEN AND METHOD FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY
French Title of Invention:
RÉGIME ET PROCÉDÉ THÉRAPEUTIQUE POUR LE TRAITEMENT OU L'AMÉLIORATION DE TROUBLES DE LA VUE ASSOCIÉS À UNE CARENCE EN RÉTINOÏDES ENDOGÈNES
German Title of Invention:
THERAPIEPLAN UND VERFAHREN ZUR BEHANDLUNG ODER LINDERUNG VON MIT EINER ENDOGENEN NETZHAUTSCHWÄCHE ASSOZIIERTEN SEHSTÖRUNGEN
SPC Number:

Dates

Filing date:
19/04/2011
Grant date:
14/10/2020
EP Publication Date:
06/03/2013
PCT Publication Date:
27/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/10/2020
EP B1 Publication Date:
14/10/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/04/2021
Expiration date:
19/04/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/10/2020
 
 

Name:
Retinagenix Therapeutics, Inc.
Address:
421 Kipling Street, Palo Alto, California 94301, United States (US)

Inventor

1

Name:
BOCH, Ronald Erwin
Address:
Canada (CA)

2

Name:
CADDEN, Suzanne
Address:
Canada (CA)

3

Name:
STRONG, H., Andrew
Address:
Canada (CA)

Priority

1

Priority Number:
325763 P
Priority Date:
19/04/2010
Priority Country:
United States (US)

2

Priority Number:
407436 P
Priority Date:
27/10/2010
Priority Country:
United States (US)

3

Priority Number:
447611 P
Priority Date:
28/02/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 31/11; A61K 31/21; A61K 31/215; A61K 31/222; A61P 27/02; A61K 47/44;

Publication

European Patent Bulletin

Issue number:
202042
Publication date:
14/10/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages